Send the following on WhatsApp
Continue to ChatGenentech 攻慢性皮膚病,新合作取得已獲得突破性治療資格的單抗藥物 Vixarelimab https://geneonline.news/genentech-vixarelimab-licensing/
Genentech 攻慢性皮膚病,新合作取得已獲得突破性治療資格的單抗藥物 Vixarelimab https://geneonline.news/genentech-vixarelimab-licensing/